Veterinary Pharmaceutical Solutions (VPS) has announced the acquisition of Diamond Animal Health, a key contract manufacturer of animal health solutions, from Mars Corporation. VPS’s acquisition of Diamond Animal Health was completed in partnership with private investment firm Granite Creek Capital Partners, L.L.C.

The acquisition is a strategic move, VPS said, that expands its position beyond its status as the market leader in livestock pharmacy compounding. Diamond Animal Health is a proven partner in contract manufacturing and research of animal vaccines and pharmaceuticals. Further, the acquisition is an opportunity for Diamond Animal Health and Veterinary Pharmaceutical Solutions to grow together and significantly broaden their capabilities in the animal health industry.

“This acquisition marks an exciting new chapter for both Veterinary Pharmaceutical Solutions and Diamond Animal Health,” said Dean Warras, chief executive officer of both entities. “We are excited to welcome Diamond Animal Health to our team as we diversify our product offerings, expand our research and development capabilities and elevate our overall operations.”

The acquisition will create an integrated animal health platform that is uniquely positioned due to three key pillars of offerings:

“The collective experience of the Veterinary Pharmaceutical Solutions and Diamond Animal Health teams will greatly benefit both organizations and enhance each of their abilities to support the industry,” said Warras. “The team at Veterinary Pharmaceutical Solutions is committed to investing for growth and bringing Diamond Animal Health under the umbrella to really strengthen our offerings.”

Laurie Peterson, general manager of Diamond Animal Health, commented: “Diamond Animal Health is excited to be part of a group that is 100% focused on animal pharmaceuticals and serving the livestock and companion animal industries. We believe that our new ownership will help us execute on serving our current customers and bring new and innovative offerings to the market in the years ahead.”

VPS said it has demonstrated its commitment to innovation by continually expanding a product pipeline through the development and acquisition of new solutions that meet the evolving needs of its loyal customer base. In addition to product innovation, VPS said it also significantly expanded its team of veterinarians, pharmacists and industry experts in 2023.